About EPEMED

EPEMED aims to create a central point of communication for all those involved in progressing personalised medicine; determine optimal routes to deliver personalised medicine treatments to patients efficiently and promote a better understanding of the development of personalised medicine through the creation and application of advanced diagnostic tests.

EPEMED is a recently formed, not-for-profit organisation. The association was founded to address issues in personalised medicine that confront the industry, regulators, payers & insurers as well as governments. The organisation is directed by a dynamic and diverse group of leaders in the personalised medicine field, who have great expertise in the application and development of diagnostic tools to deliver improved patient care.

Recent innovations in molecular diagnostics have played an important role in improving patient outcomes in a range of human diseases. Jointly with personalised therapeutics, companion diagnostics form the field of personalised medicine, where a person’s clinical, genomic and environmental information is used to more precisely select medication and dose for each individual patient. The application of personalised medicine is likely to improve patient care as well as lower healthcare costs.

As a centralised organisation promoting innovation and efficiency through personalised medicine, EPEMED plans to address the following with its partners in Europe and worldwide:

How best to develop personalised treatments?
Regulatory guidance on the co-development of diagnostic test and personalised drug therapy
Validation approaches for companion diagnostic tests
How to make personalised medicine available to patients?
Improving market access for high-value, companion diagnostics
Value-based pricing and reimbursement of diagnostic tests